Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 310.62 Million CNY | 17.58% |
| 2022 | 264.19 Million CNY | 6.93% |
| 2021 | 247.07 Million CNY | 104.73% |
| 2020 | 120.68 Million CNY | -58.88% |
| 2019 | 293.46 Million CNY | -32.73% |
| 2018 | 436.27 Million CNY | 19.78% |
| 2017 | 364.21 Million CNY | 42.36% |
| 2016 | 255.83 Million CNY | 7.72% |
| 2015 | 237.49 Million CNY | 33.35% |
| 2014 | 178.09 Million CNY | -19.54% |
| 2013 | 221.34 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 69.48 Million CNY | -18.49% |
| 2024 Q2 | 85.45 Million CNY | 22.98% |
| 2024 Q3 | 61.46 Million CNY | -28.07% |
| 2023 Q1 | 79.42 Million CNY | 11.31% |
| 2023 Q3 | 68.59 Million CNY | -11.33% |
| 2023 Q2 | 77.35 Million CNY | -2.61% |
| 2023 Q4 | 85.24 Million CNY | 24.28% |
| 2023 FY | 310.62 Million CNY | 17.58% |
| 2022 FY | 264.19 Million CNY | 6.93% |
| 2022 Q4 | 71.35 Million CNY | 16.08% |
| 2022 Q3 | 61.47 Million CNY | -11.11% |
| 2022 Q2 | 69.15 Million CNY | 11.17% |
| 2022 Q1 | 62.2 Million CNY | 0.9% |
| 2021 Q3 | 56.39 Million CNY | -7.15% |
| 2021 Q4 | 61.65 Million CNY | 9.33% |
| 2021 Q1 | 68.29 Million CNY | 1208.7% |
| 2021 FY | 247.07 Million CNY | 104.73% |
| 2021 Q2 | 60.73 Million CNY | -11.07% |
| 2020 Q4 | -6.15 Million CNY | -116.04% |
| 2020 Q3 | 38.4 Million CNY | -31.55% |
| 2020 Q2 | 56.11 Million CNY | 73.59% |
| 2020 Q1 | 32.32 Million CNY | -58.81% |
| 2020 FY | 120.68 Million CNY | -58.88% |
| 2019 FY | 293.46 Million CNY | -32.73% |
| 2019 Q4 | 78.47 Million CNY | 83.93% |
| 2019 Q3 | 42.66 Million CNY | -59.85% |
| 2019 Q1 | 66.05 Million CNY | -40.39% |
| 2019 Q2 | 106.27 Million CNY | 60.88% |
| 2018 Q1 | 90.52 Million CNY | -21.12% |
| 2018 Q3 | 96.14 Million CNY | -30.73% |
| 2018 Q4 | 110.8 Million CNY | 15.25% |
| 2018 FY | 436.27 Million CNY | 19.78% |
| 2018 Q2 | 138.8 Million CNY | 53.34% |
| 2017 Q4 | 114.75 Million CNY | 7.79% |
| 2017 FY | 364.21 Million CNY | 42.36% |
| 2017 Q1 | 43.45 Million CNY | -44.33% |
| 2017 Q3 | 106.45 Million CNY | 6.93% |
| 2017 Q2 | 99.55 Million CNY | 129.11% |
| 2016 Q4 | 78.05 Million CNY | 45.41% |
| 2016 Q3 | 53.68 Million CNY | 0.0% |
| 2016 FY | 255.83 Million CNY | 7.72% |
| 2015 FY | 237.49 Million CNY | 33.35% |
| 2014 FY | 178.09 Million CNY | -19.54% |
| 2013 FY | 221.34 Million CNY | 0.0% |